Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies.
Luis Carlos SaizLeire LeacheMarta Gutiérrez-ValenciaJuan ErvitiMaría Ximena Rojas ReyesPublished in: Therapeutic advances in hematology (2023)
10.17605/OSF.IO/V6HDX.